Although the new generation mTOR inhibitors hold great promise for anticancer therapy and are rapidly moving into clinical trials, there are many important issues that determine their success in the clinic.
The new generation mTOR inhibitors hold great promise for anticancer therapy. The new generation mTOR inhibitors are rapidly moving into clinical trials. There are many important issues. These many important issues determine their success in the clinic.